OXOS Medical vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
OXOS Medical is an Atlanta-based MedTech company developing compact, portable flat-panel X-ray imaging devices for point-of-care diagnostics; backed by strategic investors including FUJIFILM and Carestream Health;
About
OXOS Medical is an Atlanta-based medical imaging technology company focused on developing compact, portable, and intelligent X-ray imaging devices designed to bring diagnostic-quality imaging to point-of-care settings. The company's flagship product — the OXOS One — is a flat-panel, portable digital X-ray imaging device that fits in the palm of a hand and eliminates the heavy, stationary X-ray equipment traditionally required for diagnostic imaging. The OXOS One is designed for use in orthopedic offices, emergency settings, veterinary clinics, remote clinical environments, and sports medicine facilities — any setting where immediate on-site imaging improves diagnostic speed and care quality without requiring a patient to travel to a radiology suite.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.